"A woman’s physiology is different from a man’s. So, too, is her body’s response to cancer, chemotherapy, radiation and other treatments. That is why we opened the True Family Women’s Cancer Center. Our specialists focus exclusively on treating women with cancer, and the True Center offers a tremendous number of ways to give emotional support to women and their families."

During the past decade, Women's Cancer Center of Seattle conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Women's Cancer Center of Seattle" #1 collaborator was "NRG Oncology" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Women's Cancer Center of Seattle" are "Fallopian Tube Clear Cell Adenocarcinoma" (4 trials), "Fallopian Tube Transitional Cell Carcinoma" (4 trials), "Ovarian Clear Cell Adenocarcinoma" (4 trials), "Ovarian Seromucinous Carcinoma" (4 trials) and "Ovarian Serous Adenocarcinoma" (4 trials). Many other conditions were trialed in "Women's Cancer Center of Seattle" in a lesser frequency.

Most popular intervention types in "Women's Cancer Center of Seattle" are "Other" (9 trials), "Drug" (6 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (7 trials), "Laboratory Biomarker Analysis" (6 trials), "Questionnaire Administration" (6 trials), "Paclitaxel" (5 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Women's Cancer Center of Seattle" are 9 trials for "Female" genders.

Currently, there are NaN active trials in "Women's Cancer Center of Seattle". undefined are not yet recruiting, 1 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Women's Cancer Center of Seattle, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Women's Cancer Center of Seattle, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".